However, there was no significant difference in the levels of the MΦ2a or MΦ2b subtypes, or the intermediate (CD80+/CD163+/CD86+) subtype, between the CD14+low/CD68+low and CD14+high/CD68+high subpopulations for either the controls or endometriosis patients (Supplementary Fig. 2b). This evidence concerns the gene CD86 and endometriosis.